Matthew Stanton - CHIEF SCIENTIFIC OFFICER at Generation Bio Co.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
GBIO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Stanton since 7/7/2023

Holdings reported by Matthew Stanton for Generation Bio Co.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 244,955 $906 K $3.70 Apr 15, 2024 Direct
Stock Option (right to buy) 160,650 $737 K $4.59 Jan 2, 2024 Direct Common Stock
Restricted Stock Units 18,407 $68.1 K $3.70 Apr 15, 2024 Direct Common Stock

Transactions reported by Matthew Stanton for Generation Bio Co.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership